vcfirmsdirectory.com

Private equity · Buyout

LYFE Capital

LYFE Capital is a healthcare-focused investment platform with offices across Asia and the U.S., backing healthcare supply chain assets, product platforms and R&D services for institutional investors.

Menlo Park · Seoul · Shanghai · Tokyo · SingaporeRegistered · Shanghai
New investments · 12 months
Fund vehiclesPublic
None
on the registers we read
First cheque
Active portfolio
FreeRegistry entries, fund vehicles and filingsPROEverything we enrich: deals, team, events and signals
Updated 8 Nov 2026, 05:09 CETSources: lyfecapital.com · SEC adviser filings

Investment activity

Round-by-round activity is part of PRO

See every round LYFE Capital joined

Monthly deal flow, follow-ons, fund closes and exits.

Key signal this week

See all signals

Is LYFE Capital right for your round?

Is LYFE Capital a fit for your round?

Match your sector, round, size and region against where they invest, and see who to approach.

Key stats

Fund vehiclesPublic
None
on the registers we read
SEC adviser filings
First cheque
Core stage
New deals per year
Lead rate
Active portfolio
Exits

Fund cycle Public record

No fund vehicles on the public registers we read.

Deployed (new cheques)
Next fund expected

Latest investments

Rounds LYFE Capital joined, from press and the firm’s own posts.

DateCompanyRoundRound sizeRoleAlongside

Every round LYFE Capital joined

Round sizes, LYFE Capital’s role and who invested alongside.

Round-by-round history is part of PRO

Notable portfolio

ST PharmEdge MedicalProfound BioBora PharmaceuticalsBrightechNoah MedicalJeisis medicalFong’s EngineeringKangji MedicalChemLexand 4 more

Portfolio and exits

Every company LYFE Capital backed and how the exits played out.

Where the money goes

Share of companies at first investment, from the rounds we track.

Where LYFE Capital puts its money

Sector, country and stage mix across every first cheque.

Investment team

The investment team

Partners, principals and investors, with their city, focus and how to reach them.

Where to meet LYFE Capital

Events where LYFE Capital’s team spoke or showed up, from event programmes, press and the firm’s own posts.

Where to meet LYFE Capital’s partners

The events they speak at, your next chance to meet them, and which ones founders can get into.

Signals

Register and fund filings are free. Website, team and portfolio changes we pick up are PRO.

27 Mar 2026Fund filingForm ADV filed by LYFE CAPITAL INVESTMENT MANAGEMENT (SHANGHAI) CO., LTD..SEC Form ADV · public record
22 Oct 2025New deal

Founders also look at

Frequently asked questions

LYFE Capital is based in Shanghai, China. It also has offices in Menlo Park, Seoul, Tokyo and Singapore.

Stages: Buyout. Sectors: Biotech. From the firm’s own website.

LYFE Capital lists 14 portfolio companies on its website, including ST Pharm, Edge Medical, Profound Bio, Bora Pharmaceuticals and Brightech.

Firms whose websites list some of the same companies include 1955 Capital, HLC VGC MANAGEMENT IV LIMITED and Iaso Ventures.

Know before LYFE Capital’s next round is announced.

PRO tracks LYFE Capital’s filings, hires and portfolio changes the day they land, alongside 3,869 other firms.

LYFE CapitalGet LYFE Capital’s signals the day they landMonitor

Search the directory

Type a firm's name, a city or a country.